2024/11/14
Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the European Union (EU) GMP Certificates for the production line of Contrast media from Netherlands’ health supervision agency Health and Youth Care Inspectorate, indicating that Beilu pharma’s contrast media production line has successfully passed the EU GMP on-site inspection and complies with EU GMP standards. The successful of this inspection confirms that the company’s quality system fully complies with the highest international standards.
Passing the EU GMP certification creates beneficial conditions for the export of the company's contrast media products to regulated markets such as the EU, which is conducive to the company's further expansion into overseas markets, enhancing the international market competitiveness of the company's contrast media products, and will have a positive impact on the company's operations in the future.